Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages

Molecular Therapy

Volumn 8, Issue 1, 2003, Pages 62-71

  Banerjea, Akhil ^a   Li, Ming Jie ^b   Bauer, Gerhard ^b   Remling, Leila ^a   Lee, Nan Sook ^b   Rossi, John ^b   Akkina, Ramesh ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; LENTIVIRUS VECTOR; REV PROTEIN; RNA;

ANIMAL CELL; ARTICLE; CELL MATURATION; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION; GENE SILENCING; GENE THERAPY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HEMATOPOIETIC STEM CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; SCID MOUSE; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

EID: 0041903758     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00140-0     Document Type: Article

References (45)

1. Zhou, C, et al. (1994). Inhibition of HIV-1 in human T-lymphocytes by retrovirally transduced anti-tat and rev hammerhead ribozymes. Gene 149: 33-39.
2. Rossi, J. J. (1999). The application of ribozymes to HIV infection. Curr. Opin. Mol. Ther. 1: 316-322.
3. + hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture. J. Virol. 70: 4352-4360.
4. Bonyhadi, M. L., et al (1997). RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J. Virol. 71: 4707-4716.
5. Amado, R. G., Mitsuyasu, R. T., and Zack, J. A. (1999). Gene therapy for the treatment of AIDS: animal models and human clinical experience. Front. Biosci. 4: D468-475.
6. + cells from the bone marrow of human immunodeficiency virus-1-infected children. Blood 94: 368-371.
7. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., and Mello, C. C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
8. Sharp, P. A. (2001). RNA interference - 2001. Genes Dev. 15: 485-490.
9. Coburn, G. A., and Cullen, B. R. (2002). Potent and specific inhibition of human immunodeficiency virus type 1 replication by RNA interference. J. Virol. 76: 9225-9231.
10. Lee, N. S., et al. (2002). Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat. Biotechnol. 20: 500-505.
11. Novina, C. D., et al. (2002). siRNA-directed inhibition of HIV-1 infection. Nat. Med. 8: 681-686.
12. Jacque, J. M., Triques, K., and Stevenson, M. (2002). Modulation of HIV-1 replication by RNA interference. Nature 418: 379-380.
13. Qin, X.-F., An, D. S., Chen, I. S. Y., and Baltimore, D. (2003). Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc. Natl. Acad. Sci. USA 100: 183-188.
14. Emerman, M., and Malim, M. H. (1998). HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology. Science 280: 1880-1884.
15. Malim, M. H., Bohnlein, S., Hauber, J., and Cullen, B. R. (1989). Functional dissection of the HIV-1 Rev trans-activator - Derivation of a trans-dominant repressor Rev function. Cell 58: 205-214.
16. McManus, M. T., et al. (2002). Small interfering RNA-mediated silencing in T lymphocytes. J. Immunol. 169: 5754-5760.
17. Barton, G. M., and Medzhitov, R. (2002). Retroviral delivery of small interfering RNA into primary cells. Proc. Natl. Acad. Sci. USA 99: 14943-14945.
18. Pomerantz, R. J. (2002). RNA interference meets HIV-1: will silence be golden? Nat. Med. 8: 659-660.
19. McManus, T. M., and Sharp, P. A. (2002). Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 3: 737-742.
20. Weissman, I. L. (2000). Translating stem and progenitor cell biology to the clinic: barriers and opportunities. Science 287: 1442-1446.
21. Logan, A. C., Lutzko, C., and Kohn, D. B. (2002). Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Curr. Opin. Biotechnol. 13:429-436.
22. + T-cell depletion in HIV disease. Nature 410: 974-979.
23. Yam, P. Y., Shulian, L., Wu, J., Hu, J., Zaia, J. A., and Yee, J.-K. (2002). Design of HIV vectors for efficient gene delivery into human hematopoietic cells. Mol. Ther. 5: 479-484.
24. Bai, J., Banda, N., Lee, N. S., Rossi, J. J., and Akkina, R. (2002). RNA based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model. Mol. Ther. 6: 770-782.
25. Chackerian, B., Long, E. M., Luciw, P.A., and Overbaugh, J. (1997). HIV-1 co-receptors participates in post-entry stages of the virus replication cycle and function in SIV infection. J. Virol. 71: 3932-3939.
26. Kimpton, J., and Emerman, M. (1992). Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66: 2232-2239.
27. Akkina, R. K., Rosenblatt, J. D., Campbell, A. G., Chen, I. S. Y., and Zack, J. A. (1994). Modeling human lymphaid precursor cell gene therapy in SCID-hu mouse. Blood 84: 1393-1398.
28. + hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo. Mol. Ther. 1: 244-254.
29. Vodicka, M. A., et al. (1997). Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses. Virology 233: 193-198.
30. Couzin, J. (2002). Small RNAs make big splash. Science 298: 2296-2297.
31. Voinnet, O., and Baulcombe, D. C. (1997). Systemic signalling in gene silencing. Nature 389: 553.
32. Naldini, L., et al (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
33. Engel, B. C., and Kohn, B. D. (1999). Stem cell directed gene therapy. Front. Biosci. 4: E26-33.
34. Robbins, P. B., et at (1998). Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proc. Notl. Acad Sci. USA 95: 10182-10187.
35. Paddison, P. J., et al. (2002). Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16: 948-958.
36. Germain, R. N. (2002). T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 2: 309-322.
37. Banda, N. K., et al. (1998). Diphtheria toxin A gene-mediated HIV-1 protection of cord blood-derived T cells in the SCID-hu mouse model. J. Hematother. 7: 319-331.
38. Cohen, O. I., and Fauci, A. S. (2001). Pathogenesis and medical aspects of HIV-1 infection. In Fields Virology, 4th ed., pp. 2043-2094. Lippincott Williams & Wilkins, Philadelphia.
39. Bal, J., Rossi, J. J., and Akkina, R. (2001). Multi-valent anti-CCR5 ribozymes for stem cell based HIV-1 gene therapy. AIDS Res. Hum. Retroviruses 17: 385-399.
40. + cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283: 682-686.
41. Ziegler, B. L., et al. (1999). KDR receptor: a key marker defining hematopoietic stem cells. Science 285: 1553-1558.
42. Pelosi, E., et al. (2002). Identification of the hemangloblast in postnatal life. Blood 100: 3203-3208.
43. Dull, T., et al. (1998). Third generation lentivirus vector with a conditional packaging system. J. Virol. 72: 8463-8471.
44. + cells with a HIV-1 based retroviral vector pseudotyped with VSV-G. J. Virol. 70: 2581-2585.
45. Pandya, et al. (2001). Development of a Rev-independent, minimum simian immunodeficiency virus-derived vector system. Hum. Gene Ther. 12: 847-857.